As the EC is the brain area affected earliest and most severely by tau pathology in most AD cases [61,62], and to develop a non-transgenic rat model of sporadic AD, we injected human tau oligomers and tau fibrils into the medial entorhinal cortex (mEC). The gene discussed is MAPT; the disease is Alzheimer disease.